|
Articles by Heart
Center Physicians
Adult and Pediatric Cardiology Resources
Physicians at Arkansas Children’s Hospital
are continually innovating and researching new treatments
and protocols. Following are abstracts of several papers
presented by our physicians at recent international
medical conferences. We hope theses adult and pediatric
cardiology resources will be helpful to patients, parents
of patients and professionals in the field of cardiology.
For additional pediatric cardiology
resources, visit
the Web resources section, and you will find cardiology
care web sites for patients and parents of patients.
Airborne Transfer Of Patients On Excorporeal
Membrane Oxygenator (ECMO) Support
The Extra Cardiac Fontan Procedure Without
Cardiopulmonary Bypass – Technique And Intermediate Term
Results
Pediatric Arterio-Venous Extracorporeal
Membrane Oxygenation (ECMO) As A Bridge To Cardiac Transplantation
AIRBORNE TRANSFER OF PATIENTS
ON EXCORPOREAL MEMBRANE OXYGENATOR SUPPORT
William P. Fiser, Sana Ullah, LL Baker, CW Chipman, BJ Taylor,
Anji Yetman, Michael Schmitz, Stephen Van Devanter, JJ Drummond-Webb
Arkansas Children’s Hospita University of Arkansas for
Medical Science Divisions of Pediatric Cardiac Surgery, Pediatric
Cardiac Anesthesiology and Cardiology
Introduction: Airborne circulatory support during
the transport of critically ill patients imposes significant logistic,
mechanical, and physiological problems. Requirements for airborne
ECMO transportation have required circuit changes specific to a
roller-pump system with a computer aided perfusion system, custom
built frames for helicopter and fixed wing use, and the ability
to function independently of the ECMO/intensive care unit for a
prolonged period of time.
Methods: An IRB-approved database for ECMO patients
was custom-designed and maintained. This database was examined
to assess the patient outcomes. Results between 1990 and 2002:
53 patients have been transported on ECMO by air. Of these, 95%
were placed on ECMO by our team at the referral site. Three transports
occurred from the referral site to another institution. Transport
was by helicopter in 48 patients, fixed–wing aircraft in
five. Ages range from one day of life to 68 years of age. Only
eight patients were adults. The median transport distance was 150
miles (range 5-995 miles). Overall, 50% of transported patients
were long-term survivors. There was no mortality incurred during
transport. Long-term survival was only 13% in adult patients (of
which one received a cardiac transplant) and 27% amongst pediatric
patients with cardiac diagnoses. Of the pediatric cardiac transports,
27% were attempted salvages of failed cardiovascular surgical procedures
at other institutions. There was only one survivor in this group.
Significantly increased long-term survival (73%, p<.01) was
noted amongst neonates and pediatric patients with medical diagnoses.
Step-wise logistic regression failed to document age to be statistically
significant, and medical diagnosis vs cardiac diagnosis was highly
significant (p<.01).
Conclusion: Transplantation after ECMO placement
can be safely achieved, provided appropriate air, medical, and
physiologic considerations are taken into account. Long-term survival
was affected by the preintervention diagnosis. Children with a
noncardiac illness requiring ECMO airborne transport have a much
better chance of survival vs children with a cardiac diagnosis.
Adults and patients who have failed cardiac surgery have a very
poor prognosis.
Back to Top
THE EXTRA CARDIAC FONTAN PROCEDURE
WITHOUT CARDIOPULMONARY BYPASS – TECHNIQUE AND INTERMEDIATE
TERM RESULTS
Anji T. Yetman, M.D., Jonathan Drummond-Webb, M.D.,
William P. Fiser, M.D., Michael L. Schmitz, M.D. ,
Michiaki Imamura, M.D.,PhD, Sana Ullah, M.D.,
Ryan J. Gunselman, BSPS, Carl W Chipman, RN, CCP, Charles E. Johnson
RN, CCP , Stephen H. Van Devanter, M.D.
Extracardiac Fontan Without Bypass
From the department of Cardiovascular Surgery, Pediatric
Cardiovascular Anesthesiology, and Pediatric Cardiology . The
University of Arkansas for Medical Sciences and Arkansas Children’s
Hospital, 800 Marshall Street, Little Rock, Arkansas 72202-3591
MEETING PRESENTATION: Current Trends in Thoracic
Surgery VIII. Best Five Original Presentations. January 23 - 26,
2002. Miami, Florida.
Jonathan Drummond-Webb, M.D.
Chief, Department of Pediatric Cardiovascular Surgery
Arkansas Children’s Hospital
800 Marshall Street, Slot 677, Little Rock AR 72202-3591
ABSTRACT
Background: The extracardiac Fontan usually requires
the use of cardiopulmonary bypass. Results and techniques of this
procedure without cardiopulmonary bypass at a single institution
are presented.
Methods: Between August 1992 and December 2001,
the extracardiac Fontan procedure without cardiopulmonary bypass
was achieved in 24 out of 44 patients undergoing extracardiac Fontan.
Mean age at surgery was 5.9 ± 2.9 years and mean weight
20.7 ± 12.6 kg. Diagnoses were tricuspid atresia in 9 patients,
single ventricle with pulmonary outflow tract obstruction in 7,
pulmonary atresia /intact septum in 5, and other complex single
ventricle physiology in 3. Initial palliation was by arterial to
pulmonary artery shunt in 21 and pulmonary artery banding in 1.
A bi-directional cavopulmonary connection was created in 23 patients.
A temporary inferior vena caval to atrial shunt was used to complete
the procedure without cardiopulmonary bypass. Median graft size
was 16mm (range 14-20 mm).
Results: There was no early mortality, and 68%
were discharged without complications. Complications included persistent
cyanosis in 4, persistent pleural effusions, in 2 (1 chylous),
and one phrenic nerve injury. Median postoperative hospital stay
was 16 (10-50) days. At a mean follow-up of 44 ± 28 months,
there was no conduit obstruction. One patient died 11 months post
operatively, and one patient received a heart transplant 26 months
post ECF.
Conclusion: At intermediate term follow-up, the ECF
without CPB appears safe and technically reproducible in selected
cases. Ongoing follow-up of these patients is necessary to document
the theoretical advantages of avoiding CPB.
Back to Top
PEDIATRIC ARTERIO-VENOUS EXTRACORPOREAL
MEMBRANE OXYGENATION (ECMO) AS A BRIDGE TO CARDIAC TRANSPLANTATION
*William P. Fiser, M.D., #Anji T. Yetman, M.D., *Ryan J. Gunselman,
#James W Fasules, M.D., *Lorrie L. Baker, R.N., *Carl W. Chipman,
R.N., C.C.P., # William R Morrow M.D., #Elizabeth A. Frazier,
M.D., *Jonathan J. Drummond-Webb, M.D.;
*Pediatric and Congenital Cardiac Surgery, Arkansas Children's
Hospital, Little Rock, AR, United States; Surgery and Division
of Cardiothoracic Surgery, University of Arkansas for Medical Sciences,
Little Rock, AR, United States; #Pediatric Cardiology, Arkansas
Children's Hospital, Little Rock, AR, United States.
Corresponding Author:
Jonathan Drummond-Webb, M.D.
Arkansas Children’s Hospital
Chief of Pediatric and Congenital Cardiac Surgery
800 Marshall Street, Slot 677
Little Rock, AR 72202
ABSTRACT
Background: Since 1990, ECMO has been used as
a bridge to cardiac transplantation in 47 patients.
Methods: A review of the ACH, IRB approved, ECMO
database forms the basis of this report. Statistical comparison
used Fisher exact probability testing. ECMO circuitry was a roller
occlusion pump with computerized assisted perfusion system technology.
Results: Trans-catheter septostomy was used for
cardiac decompression in 32 (68%) patients. Diagnosis at presentation
was either congenital heart disease (CHD) N=15 or cardiomyopathy
(CM) N=32. Ages ranged from 1 day to 22 years (median 18 months)
and weight ranged from 2.9 to 100 kg (median 10 kg). The average
duration of support was 242 hours (range 22-1078 hours). Overall
long-term survival was 47% with 16 (34%) patients successfully
bridged to cardiac transplant (of which 9 [56%] survived) and 13
(28%) successfully weaned from ECMO. Patients placed on ECMO post-cardiotomy
had a 31% survival. Survival was significantly improved (p< .02)
in patients with a diagnosis of CM (59%) versus those with CHD
(20%). Patients with CM underwent 8 transplants with 7 survivors
(88%), while in the CHD group, there were 8 transplants with only
2 survivors (25%), (p< .05). Sub analysis of the CM group revealed
that patients with acute cardiomyopathy in association with a documented
viral illness had a 75% chance of being weaned off ECMO without
transplant. Complications on ECMO occurred in 45% of survivors
and were more frequent in non-survivors. Infectious complications
were most frequent, followed by neurological, technical ECMO problems
and renal insufficiency.
Conclusions: In conclusion, CM has a better prognosis
than CHD when using ECMO as a bridge to transplant or survival.
Complications are not insignificant and increase with the duration
of support. ECMO for salvage and subsequent transplant in this
high-risk group of patients needs critical review. Alternative
support options need to be developed in the pediatric population
that will allow improved outcomes comparable to those achieved
by our adult support colleagues.
Back to Top
|